Medical Coatings Market

Medical Coatings Market by Coating Type (Active, Passive), Material Type (Polymers, Metals), Application (Medical Devices, Medical Implants, Medical Equipment & Tools, Protective Clothing), and Region - Global Forecast to 2025

Report Code: CH 3023 Aug, 2020, by marketsandmarkets.com

[192 Pages Report] The global medical coatings market size is projected to grow from USD 6.0 billion in 2020 to USD 15.2 billion by 2025, at a CAGR of 20.5% during the forecast period. The growth of this market can be attributed to the rising income levels in emerging economies, a growing percentage of the geriatric population, and the increasing use of home healthcare facilities. Also, the increasing demand for minimally invasive surgical procedures is also anticipated to drive the growth of the medical coatings market.

Attractive Opportunities In The Medical Coatings Market

To know about the assumptions considered Request for Free Sample Report

COVID-19 Impact on Medical Coatings Market

The medical coatings market includes major Tier I and II manufacturers like DSM, Hydromer, Surmodics, Biocoat and AST Products. These suppliers have their manufacturing facilities spread across various countries across Asia Pacific, Europe, North America, South America, and Middle East & Africa. COVID-19 has impacted their businesses as well. 

  • In April 2020, Hydromer partnered with N8 Medical for the supply of coatings to manufacture CeraShield endotracheal tubes. These tubes play a crucial role in the treatment of COVID-19 patients. This development exhibits active involvement of the company in the coatings market. 

The COVID-19 pandemic is spreading rapidly. 15,236,977 positive cases have been registered as of mid-July, 2020. The European Commission recently adopted a proposal on April 3, 2020, to postpone the application date of Medical Devices Regulation (MDR) for one year. The European Commission has recently approved revised harmonized standards to expedite the production of medical face masks, gloves, containers for intravenous injections, and sterilization devices and disinfectants, and alter particular requirements for emergency and transport ventilators. FDA has also issued Emergency Use Authorizations (EUA) for medical devices, including IVD test kits to diagnose COVID-19 and PPE (gloves, gowns, and masks) needed to protect healthcare providers interacting with patients. 

Medical Coatings Market Dynamics

Driver: Increasing use of minimally invasive surgical procedures

In a minimally invasive surgery, doctors use a variety of techniques to operate with less damage to the body than with open surgery. Minimally invasive surgery is associated with less pain, a shorter hospital stay, and fewer complications. This type of surgery offers many benefits compared to traditional open surgery techniques. In many cases, it also offers a higher accuracy rate compared to traditional open surgery. The importance of less invasive medical procedures over conventional surgical procedures is increasing. The increasing prevalence of arthritis, cancer, and cardiovascular diseases, which require complex surgical treatment, has increased the demand for minimally invasive procedures. This has boosted the consumption of lightweight medical devices, such as intravascular catheters, guidewires, balloon angioplasty catheters, delivery sheaths, and implant delivery systems that can navigate through complex and sensitive parts of the body. These devices are commonly used during minimally invasive procedures in cerebrovascular, cardiovascular, and peripheral vascular systems. They often have hydrophilic and hydrophobic coatings for easy insertion of such devices into narrow vascular areas with a reduction in tissue damage. Thus, medical coatings play a major role in promoting cost efficiency and less time consumption and are highly preferred in these medical procedures. For instance, use of coatings on medical devices for cardiac and urinary catheterization procedures significantly reduces the time taken for the concerned medical or surgical procedure.

Restraint: High upfront costs and increasing raw material prices

Medical coatings manufacturing entails huge up-front and continuing costs. There are many old or expired patents in this field, and medical coating developers are not allowed to develop new coatings based on past patents to avoid royalty. Hence, up-front payments are required to access expired technology. This factor is restraining the growth of this market. Eliminating all of the up-front costs and hassles is expected to enable the explosion of technology improvements. Formulation of new medical coatings involves legal wrangling, signing nondisclosure agreements, and other expenses. The rising cost of raw materials, such as silicone rubber and PTFE, are also inhibiting the medical coatings market growth to some extent.

Opportunity: Complex design of medical devices demanding atomic layer deposition

The scope of applications of medical coatings is quite high, owing to their functional properties. There is an increasing focus on the advancements of medical devices used in treatment, mitigation, diagnosis, and prevention of diseases and abnormal physical conditions. The medical technology sector experiences continuous evolution; major focus areas are innovative imaging devices and systems, minimally invasive therapeutic products, combination device and drug/biological products, computerized devices and medical IT systems, home- and self-care products, patient monitoring systems, and artificial organs and organ-assistive products. Innovation instruments range from simple surgical instruments, such as tongue depressors and bedpans, to complex programmable pacemakers with microchip technology and laser surgical devices. Rising complexity of medical devices has led to the use of a variety of materials to manufacture these devices. However, materials used to manufacture these devices are not necessarily biocompatible and hemocompatible. To provide the desired properties to the devices, the demand for medical coatings is expected to increase. Coatings can be required to cover the entire complex structure or just part of the complex structure, and it is required to adhere to a variety of materials used within a device. Market players are developing surface treatment methods and techniques to keep up with improvements to existing substrates, as well as newly developed substrates and polymers.

The complex nature of medical devices necessitates atomic layer deposition of a coating to form a uniform layer in the targeted area of a device. Advancements in medical device designing also require the use of nanotechnology that enables deposition of multiple coating layers and helps in eliminating defects and enhance biocompatibility. Continuous developments in medical technology present an opportunity for medical coating manufacturers to develop the best solutions for critical end-use requirements.

Challenge:Stringent and time-consuming regulatory approval process

All medical devices need to undergo design verification tests to demonstrate if they meet the specifications and, therefore, require time for approval. Regulatory bodies do not approve coatings separately. Medical OEMs have different coating materials and methodology options to choose for medical devices. The involvement of the coating supplier in the early stage of product development cycle is extremely beneficial to OEMs and can positively affect the development speed, efficiency, and cost. The coated device needs to be approved or cleared by regulatory bodies. However, some coating manufacturers perform tests on their coatings to maintain high quality. Major coating manufacturers in the market also maintain a Master File with the FDA, which shows all proprietary ingredients and processes involved with the product. A device manufacturer can incorporate this by referring to their regulatory submissions. This may save time for device development. However, the regulatory approval process remains time-consuming. The approval time varies largely according to device types. On average, the FDA takes more than three months to approve a medical device. Many coating manufacturers provide regulatory services to their customers, under which they may provide regulatory filing support and coating design requirement verification and validation process. Changes in regulations can affect medical device manufacturers as well as medical coating manufacturers. FDA regulations are likely to become more complicated and expensive in the future.  

Passive coatings to be the largest coating type segment

The passive coatings segment accounts for the largest share of the overall market. Hydrophilic coatings are widely used on guidewires, catheters, and introducer sheaths to lower friction coefficient. These coatings have properties such as lubricity, durability, low friction coefficient, and low particulate count. Hydrophobic coatings are water- or fluid-repellent and hence suitable for medical equipment. Minimal invasion and easy insertion of medical devices in biological openings offered by the hydrophilic coatings and excellent water repellent properties exhibited by the hydrophobic coatings are responsible for the large market size of passive medial coatings.  

Polymers to be the fastest-growing material type segment 

Polymer-based medical coatings are used in medical devices, medical equipment & tools, protective clothing, and medical implants. They are necessary to optimize durability and corrosion resistance while minimizing the coefficient of friction. Major subtypes of polymer coatings used on medical devices, medical implants, and other applications are fluoropolymers, silicone, parylene, and polyurethanes. Easy availability, low cost, optimum performance, multifunctionality, and low particulate technology are boosting the polymer-based medical coatings market. 

Medical devices to be the fastest-growing application segment 

The medical coatings market is segmented based on application into medical devices, medical implants, medical equipment & tools, protective clothing, and others. The medical devices segment accounted for the largest market share in 2019. Increased use of medical devices in the emerging economies, such as China and India, has led to the high growth of the market. The pandemic has further increased the demand for medical devices, such as catheters, guidewires, endotracheal tubes, positive pressure breathing devices, in-vitro diagnostic devices, cannulas, ventilators, ventilator accessories, infusion pumps, respirators, and other devices. 

North America to account for the largest market share

North America accounted for the largest share of the medical coatings market in 2019. Increased spending in the healthcare industry is driving the market for medical coatings in the region. The US was the largest medical coatings market in the region in 2019. Growing exports of medical devices, along with advancements in medical technology and increasing demand for home healthcare, are fueling the market in the region.

Medical Coatings Market By Region

To know about the assumptions considered for the study, download the pdf brochure

Key Market Players 

The medical coatings market comprises major players such DSM (Netherlands), Hydromer (US), Surmodics (US), Biocoat (US), and  AST Products (US). Hydomer is among the leading medical coatings manufacturers globally. New product launch and investment & expansion were the key strategies adopted by the company to penetrate the global medical coatings market.

Scope of the Report:

Report Metric

Details

Years Considered for the study

2018-2025

Base year

2019

Forecast period

2020-2025

Units considered

Volume (Kiloton and Ton)
Value (USD Billion and Million)

Segments

Coating Type, Material Type, Application, and Region

Regions

North America, APAC, Europe, South America, and Middle East & Africa

Companies

DSM (Netherlands),  Hydromer (US), Surmodics (US), Biocoat (US), AST Products (US), Total 25 major players covered

This research report categorizes the medical coatings market based on type, application, and region.

Based on coating type:

  • Active coatings
  • Passive coatings

Based on material type:

  • Polymers
  • Metals
  • Others

Based on the application:

  • Medical Devices
  • Medical Implants
  • Medical Equipment & Tools
  • Protective Clothing
  • Others

Based on the region:

  • APAC
  • Europe
  • North America
  • South America
  • Middle East & Africa

Recent Developments

  • In 2020, Hydromer partnered with N8 Medical for the supply of coatings to manufacture CeraShield endotracheal tubes. These tubes play a crucial role in the treatment of COVID-19 patients. This development exhibits active involvement of the company in the coatings market.
  • In 2018, Abbott and Surmodics entered into an agreement, under which, Abbott will have exclusive worldwide commercialization rights for Surmodics' SurVeil drug-coated balloons. These balloons are under the US pivotal clinical trial to treat superficial femoral artery.
  • In 2020, Biocoat launched of HYDAK UV. The new version of its original HYDAK coating is cured using ultraviolet (UV) light. This coating allows for flexible integration with industry-standard UV coating systems. This development has expanded the company’s product portfolio
  • In 2016, DSM Biomedical partnered with Vention Medical, a global integrated solutions partner. The partnership offers integration of development, testing, and application of DSM’s ComfortCoat coating into the catheter manufacturing process. This development eliminates the need to transfer finished products to another supplier for development and coating application services. 

Frequently Asked Questions (FAQ):

To speak to our analyst for a discussion on the above findings, click Speak to Analyst

TABLE OF CONTENTS

1 INTRODUCTION (Page No. - 25)
    1.1 OBJECTIVES OF THE STUDY
    1.2 MARKET DEFINITION
    1.3 MARKET SCOPE
           1.3.1 MEDICAL COATINGS MARKET SEGMENTATION
           1.3.2 REGIONS COVERED
           1.3.3 YEARS CONSIDERED FOR THE STUDY
    1.4 CURRENCY
    1.5 UNIT CONSIDERED
    1.6 STAKEHOLDERS
    1.7 LIMITATIONS
    1.8 SUMMARY OF CHANGES

2 RESEARCH METHODOLOGY (Page No. - 30)
    2.1 RESEARCH DATA
           FIGURE 1 MEDICAL COATINGS MARKET: RESEARCH DESIGN
           2.1.1 SECONDARY DATA
                    2.1.1.1 Key data from secondary sources
           2.1.2 PRIMARY DATA
                    2.1.2.1 Key data from primary sources
                    2.1.2.2 Key industry insights
                    2.1.2.3 Breakdown of primary interviews
    2.2 MARKET SIZE ESTIMATION
           2.2.1 BOTTOM-UP APPROACH
                    FIGURE 2 MEDICAL COATINGS MARKET: BOTTOM-UP APPROACH
           2.2.2 TOP-DOWN APPROACH
                    FIGURE 3 MEDICAL COATINGS MARKET: TOP-DOWN APPROACH
    2.3 DATA TRIANGULATION
           FIGURE 4 MEDICAL COATINGS MARKET: DATA TRIANGULATION
           2.3.1 MEDICAL COATINGS MARKET ANALYSIS THROUGH PRIMARY INTERVIEWS
                    FIGURE 5 MEDICAL COATINGS MARKET ANALYSIS THROUGH SECONDARY SOURCES
                    FIGURE 6 MEDICAL COATINGS MARKET ANALYSIS
    2.4 LIMITATIONS
    2.5 ASSUMPTIONS

3 EXECUTIVE SUMMARY (Page No. - 39)
    FIGURE 7 PASSIVE COATINGS SEGMENT TO LEAD THE MARKET
    FIGURE 8 POLYMERS TO BE THE LEADING MATERIAL TYPE OF MEDICAL COATINGS
    FIGURE 9 MEDICAL DEVICES SEGMENT WAS LARGEST APPLICATION OF MEDICAL COATINGS IN 2019
    FIGURE 10 NORTH AMERICA WAS THE LARGEST MEDICAL COATINGS MARKET IN 2019

4 PREMIUM INSIGHTS (Page No. - 43)
    4.1 ATTRACTIVE OPPORTUNITIES IN MEDICAL COATINGS MARKET
           FIGURE 11 GROWTH OF MEDICAL DEVICE SECTOR TO DRIVE MEDICAL COATINGS MARKET
    4.2 MEDICAL COATINGS MARKET SIZE, BY COATING TYPE
           FIGURE 12 PASSIVE COATINGS TO DOMINATE THE MARKET
           FIGURE 13 POLYMERS SEGMENT TO DOMINATE MEDICAL COATINGS MARKET
    4.3 MEDICAL COATINGS MARKET, BY APPLICATION
           FIGURE 14 MEDICAL DEVICES TO BE THE LARGEST SEGMENT
    4.4 NORTH AMERICA: MEDICAL COATINGS MARKET, BY APPLICATION AND COUNTRY, 2019
           FIGURE 15 US AND MEDICAL DEVICES SEGMENT ACCOUNTED FOR LARGEST SHARES
    4.5 MEDICAL COATINGS MARKET, BY MAJOR COUNTRIES
           FIGURE 16 INDIA TO REGISTER HIGHEST CAGR BETWEEN 2020 AND 2025

5 MARKET OVERVIEW (Page No. - 46)
    5.1 MARKET DYNAMICS
           FIGURE 17 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES IN MEDICAL COATINGS MARKET
           5.1.1 DRIVERS
                    5.1.1.1 Growth in population, income levels, and health awareness
                               FIGURE 18 INCREASING GERIATRIC POPULATION TO DRIVE MEDICAL COATINGS MARKET
                               FIGURE 19 GROWING GDP TO INCREASE HEALTHCARE INVESTMENTS
                    5.1.1.2 Increasing use of minimally invasive surgical procedures
                    5.1.1.3 Rising demand for home healthcare
                    5.1.1.4 Rapid spread of COVID-19 and high risk of HAIs
           5.1.2 RESTRAINTS
                    5.1.2.1 High upfront costs and increasing raw material prices
                    5.1.2.2 Low shelf life of coatings
           5.1.3 OPPORTUNITIES
                    5.1.3.1 Emergence of nanotechnology and growing market for multifunctional coatings
                    5.1.3.2 Complex design of medical devices demanding atomic layer deposition
           5.1.4 CHALLENGES
                    5.1.4.1 Stringent and time-consuming regulatory approval process
                    5.1.4.2 Variations in regulations across countries
    5.2 TECHNOLOGY ANALYSIS
    5.3 TARIFFS AND REGULATIONS
    5.4 COVID-19 IMPACT
    5.5 AVERAGE SELLING PRICE ANALYSIS
    5.6 CASE STUDY ANALYSIS
    5.7 VALUE CHAIN ANALYSIS
           FIGURE 20 OVERVIEW OF MEDICAL COATINGS VALUE CHAIN
           5.7.1 RAW MATERIAL SUPPLIERS
           5.7.2 MANUFACTURERS
           5.7.3 DEVICE MANUFACTURERS
           5.7.4 CONTRACT MANUFACTURERS
           5.7.5 VALUE ADDITION
           5.7.6 REGULATORY BODIES
           5.7.7 INDUSTRIAL AND INSTITUTIONAL R&D
           5.7.8 HEALTHCARE PROVIDERS
    5.8 PORTER’S FIVE FORCES ANALYSIS
           FIGURE 21 PORTER’S FIVE FORCES ANALYSIS OF MEDICAL COATINGS MARKET
           5.8.1 BARGAINING POWER OF SUPPLIERS
           5.8.2 BARGAINING POWER OF BUYERS
           5.8.3 THREAT OF SUBSTITUTES
           5.8.4 THREAT OF NEW ENTRANTS
           5.8.5 INTENSITY OF RIVALRY

6 MEDICAL COATINGS MARKET, BY TYPE (Page No. - 62)
    6.1 INTRODUCTION
    6.2 MEDICAL COATINGS MARKET, BY COATING TYPE
           FIGURE 22 PASSIVE COATINGS TO ACCOUNT FOR LARGER MARKET SHARE
           TABLE 1 MEDICAL COATINGS MARKET SIZE, BY COATING TYPE, 2018–2025 (KILOTON)
           TABLE 2 MEDICAL COATINGS MARKET SIZE , BY COATING TYPE, 2018–2025 (USD MILLION)
           6.2.1 ACTIVE COATINGS
                    TABLE 3 MEDICAL COATINGS MARKET SIZE, BY ACTIVE COATING TYPE, 2018–2025 (KILOTON)
                    TABLE 4 MEDICAL COATINGS MARKET SIZE, BY ACTIVE COATING TYPE, 2018–2025 (USD MILLION)
                    6.2.1.1 Antimicrobial coatings
                               6.2.1.1.1 Used to prevent microbial infection on medical devices
                    6.2.1.2 Others
                               6.2.1.2.1 Antithrombogenic coatings
                               6.2.1.2.2 Drug-eluting coatings
                               6.2.1.2.3 Anti-fog coatings
           6.2.2 PASSIVE COATINGS
                    TABLE 5 MEDICAL COATINGS MARKET SIZE, BY PASSIVE COATING TYPE, 2018–2025 (KILOTON)
                    TABLE 6 MEDICAL COATINGS MARKET SIZE, BY PASSIVE COATING TYPE, 2018–2025 (USD MILLION)
                    6.2.2.1 Hydrophilic coatings/lubricious hydrophilic coatings
                               6.2.2.1.1 Increasing awareness of minimally invasive procedures to drive the demand for hydrophilic medical coatings
                    6.2.2.2 Hydrophobic coatings
                               6.2.2.2.1 Excellent water resistance of these coatings to fuel the market
    6.3 MEDICAL COATINGS MARKET, BY MATERIAL TYPE
           FIGURE 23 POLYMERS TO ACCOUNT FOR LARGEST MARKET SHARE
           TABLE 7 MEDICAL COATINGS MARKET SIZE , BY MATERIAL TYPE, 2018–2025 (KILOTON)
           TABLE 8 MEDICAL COATINGS MARKET SIZE, BY MATERIAL TYPE, 2018–2025 (USD MILLION)
           6.3.1 POLYMERS
                    6.3.1.1 Fluoropolymers
                               6.3.1.1.1 PTFE
                                             6.3.1.1.1.1 Has low friction release and resistance to heat and chemicals
                               6.3.1.1.2 PVDF
                                             6.3.1.1.2.1 Highly durable and chemical-resistant
                               6.3.1.1.3 Others
                    6.3.1.2 Parylene
                               6.3.1.2.1 Transparent with a coefficient of friction similar to PTFE
                    6.3.1.3 Silicones
                               6.3.1.3.1 Biocompatibility of silicones to drive their use in medical applications
                    6.3.1.4 Others
           6.3.2 METALS
                    6.3.2.1 Silver
                               6.3.2.1.1 Used as an antimicrobial coating
                    6.3.2.2 Titanium
                               6.3.2.2.1 Generally used in implant applications due to its biocompatibility
                    6.3.2.3 Others
           6.3.3 OTHERS

7 MEDICAL COATINGS MARKET, BY SUBSTRATE TYPE (Page No. - 73)
    7.1 INTRODUCTION
    7.2 MEDICAL COATINGS, BY SUBSTRATE TYPE
           7.2.1 METALS
                    7.2.1.1 Titanium
                    7.2.1.2 Stainless steel
                    7.2.1.3 Others
           7.2.2 CERAMICS
           7.2.3 POLYMERS
                    7.2.3.1 Fluoropolymers
                    7.2.3.2 Silicone
                    7.2.3.3 Other polymers
           7.2.4 COMPOSITES
           7.2.5 GLASS

8 MEDICAL COATINGS MARKET, BY APPLICATION (Page No. - 76)
    8.1 INTRODUCTION
           FIGURE 24 MEDICAL DEVICES SEGMENT TO ACCOUNT FOR LARGEST MARKET SHARE
           TABLE 9 MEDICAL COATINGS MARKET, BY APPLICATION, 2018–2025 ( KILOTON)
           TABLE 10 MEDICAL COATINGS MARKET, BY APPLICATION, 2020–2025 (USD MILLION)
    8.2 MEDICAL DEVICES
           8.2.1 INCREASING DEMAND FOR MINIMALLY INVASIVE SURGICAL PROCEDURES TO BOOST THE MARKET
    8.3 MEDICAL IMPLANTS
           8.3.1 ORTHOPEDIC IMPLANTS
                    8.3.1.1 Coatings offer lubricity and fatigue strength to orthopedic implants
           8.3.2 DENTAL IMPLANTS
                    8.3.2.1 Dental implants coated with hydroxyapatite (HAP) stimulate bone healing
           8.3.3 CARDIOVASCULAR IMPLANTS
                    8.3.3.1 Nanomaterial coatings are used for stents
    8.4 MEDICAL EQUIPMENT & TOOLS
           8.4.1 SURGICAL EQUIPMENT & TOOLS
                    8.4.1.1 Coatings offer antimicrobial and other functional properties to surgical tools
           8.4.2 INSTITUTIONAL EQUIPMENT
                    8.4.2.1 Hydrophobic coatings are used for this equipment
    8.5 PROTECTIVE CLOTHING
           8.5.1 RAPID SPREAD OF COVID-19 DRIVING THE CONSUMPTION OF PROTECTIVE CLOTHING
    8.6 OTHERS

9 MEDICAL COATINGS MARKET, BY REGION (Page No. - 82)
    9.1 INTRODUCTION
           FIGURE 25 MEDICAL COATINGS MARKET IN INDIA TO REGISTER THE HOGHEST CAGR
           TABLE 11 MEDICAL COATINGS MARKET SIZE, BY REGION, 2018–2025 (KILOTON)
           TABLE 12 MEDICAL COATINGS MARKET SIZE, BY REGION, 2018–2025 (USD MILLION)
    9.2 NORTH AMERICA
           FIGURE 26 NORTH AMERICA: MEDICAL COATINGS MARKET SNAPSHOT
           TABLE 13 NORTH AMERICA: MEDICAL COATINGS MARKET SIZE, BY COUNTRY, 2018–2025 (KILOTON)
           TABLE 14 NORTH AMERICA: MEDICAL COATINGS MARKET SIZE, BY COUNTRY, 2018–2025 (USD MILLION)
           TABLE 15 NORTH AMERICA: MEDICAL COATINGS MARKET SIZE, BY APPLICATION, 2018–2025 (KILOTON)
           TABLE 16 NORTH AMERICA: MEDICAL COATINGS MARKET SIZE, BY APPLICATION, 2018–2025 (USD MILLION)
           9.2.1 US
                    9.2.1.1 Advancements in medical technology to propel the market
                               TABLE 17 US: MEDICAL COATINGS MARKET SIZE, BY APPLICATION, 2018–2025 (KILOTON)
                               TABLE 18 US: MEDICAL COATINGS MARKET SIZE, BY APPLICATION, 2018–2025 (USD MILLION)
           9.2.2 CANADA
                    9.2.2.1 Rising exports to boost the demand for medical coatings
                               TABLE 19 CANADA: MEDICAL COATINGS MARKET SIZE, BY APPLICATION, 2018–2025 (KILOTON)
                               TABLE 20 CANADA: MEDICAL COATINGS MARKET SIZE, BY APPLICATION, 2018–2025 (USD MILLION)
           9.2.3 MEXICO
                    9.2.3.1 Growth in domestic production activities to drive the market
                               TABLE 21 MEXICO: MEDICAL COATINGS MARKET SIZE, BY APPLICATION, 2018–2025 (KILOTON)
                               TABLE 22 MEXICO: MEDICAL COATINGS MARKET SIZE, BY APPLICATION, 2018–2025 (USD MILLION)
    9.3 EUROPE
           FIGURE 27 EUROPE: MEDICAL COATINGS MARKET SNAPSHOT
           TABLE 23 EUROPE: MEDICAL COATINGS MARKET SIZE, BY COUNTRY, 2018–2025 (KILOTON)
           TABLE 24 EUROPE: MEDICAL COATINGS MARKET SIZE, BY COUNTRY, 2018–2025 (USD MILLION)
           TABLE 25 EUROPE: MEDICAL COATINGS MARKET SIZE, BY APPLICATION, 2018–2025 (KILOTON)
           TABLE 26 EUROPE: MEDICAL COATINGS MARKET SIZE, BY APPLICATION, 2018–2025 (USD MILLION)
           9.3.1 GERMANY
                    9.3.1.1 Innovations in medical technology to drive the market
                               TABLE 27 GERMANY: MEDICAL COATINGS MARKET SIZE, BY APPLICATION, 2018–2025 (KILOTON)
                               TABLE 28 GERMANY: MEDICAL COATINGS MARKET SIZE, BY APPLICATION, 2018–2025 (USD MILLION)
           9.3.2 FRANCE
                    9.3.2.1 Presence of a well-established medical device manufacturing industry to boost the market
                               TABLE 29 FRANCE: MEDICAL COATINGS MARKET SIZE, BY APPLICATION, 2018–2025 (KILOTON)
                               TABLE 30 FRANCE: MEDICAL COATINGS MARKET SIZE, BY APPLICATION, 2018–2025 (USD MILLION)
           9.3.3 UK
                    9.3.3.1 Government initiatives for collaborative developments in medical technology to drive the market
                               TABLE 31 UK: MEDICAL COATINGS MARKET SIZE, BY APPLICATION, 2018–2025 (KILOTON)
                               TABLE 32 UK: MEDICAL COATINGS MARKET SIZE, BY APPLICATION, 2018–2025 (USD MILLION)
           9.3.4 ITALY
                    9.3.4.1 Fourth-largest medical technology market in Europe
                               TABLE 33 ITALY: MEDICAL COATINGS MARKET SIZE, BY APPLICATION, 2018–2025 (TON)
                               TABLE 34 ITALY: MEDICAL COATINGS MARKET SIZE, BY APPLICATION, 2018–2025 (USD MILLION)
           9.3.5 RUSSIA
                    9.3.5.1 Rising demand for minimally invasive procedures to spur the market
                               TABLE 35 RUSSIA: MEDICAL COATINGS MARKET SIZE, BY APPLICATION, 2018–2025 (TON)
                               TABLE 36 RUSSIA: MEDICAL COATINGS MARKET SIZE, BY APPLICATION, 2018–2025 (USD MILLION)
           9.3.6 SPAIN
                    9.3.6.1 Among the largest consumers of medical coatings in the region
                               TABLE 37 SPAIN: MEDICAL COATINGS MARKET SIZE, BY APPLICATION, 2018–2025 (TON)
                               TABLE 38 SPAIN: MEDICAL COATINGS MARKET SIZE, BY APPLICATION, 2018–2025 (USD MILLION)
           9.3.7 REST OF EUROPE
                    TABLE 39 REST OF EUROPE: MEDICAL COATINGS MARKET SIZE, BY APPLICATION, 2018–2025 (TON)
                    TABLE 40 REST OF EUROPE: MEDICAL COATINGS MARKET SIZE, BY APPLICATION, 2018–2025 (USD MILLION)
    9.4 APAC
           FIGURE 28 APAC: MEDICAL COATINGS MARKET SNAPSHOT
           TABLE 41 APAC: MEDICAL COATINGS MARKET SIZE, BY COUNTRY, 2018–2025 (KILOTON)
           TABLE 42 APAC: MEDICAL COATINGS MARKET SIZE, BY COUNTRY, 2018–2025 (USD MILLION)
           TABLE 43 APAC: MEDICAL COATINGS MARKET SIZE, BY APPLICATION, 2018–2025 (KILOTON)
           TABLE 44 APAC: MEDICAL COATINGS MARKET SIZE, BY APPLICATION, 2018–2025 (USD MILLION)
           9.4.1 CHINA
                    9.4.1.1 Third-largest medical device manufacturing market globally
                               TABLE 45 CHINA: MEDICAL COATINGS MARKET SIZE, BY APPLICATION, 2018–2025 (KILOTON)
                               TABLE 46 CHINA: MEDICAL COATINGS MARKET SIZE, BY APPLICATION, 2018–2025 (USD MILLION)
           9.4.2 JAPAN
                    9.4.2.1 Increasing percentage of geriatric population to drive the market
                               TABLE 47 JAPAN: MEDICAL COATINGS MARKET SIZE, BY APPLICATION, 2018–2025 (KILOTON)
                               TABLE 48 JAPAN: MEDICAL COATINGS MARKET SIZE, BY APPLICATION, 2018–2025 (USD MILLION)
           9.4.3 SOUTH KOREA
                    9.4.3.1 Continuous R&D activities to fuel the medical device market
                               TABLE 49 SOUTH KOREA: MEDICAL COATINGS MARKET SIZE, BY APPLICATION, 2018–2025 (TON)
                               TABLE 50 SOUTH KOREA: MEDICAL COATINGS MARKET SIZE, BY APPLICATION, 2018–2025 (USD MILLION)
           9.4.4 INDIA
                    9.4.4.1 Creation of medical device cluster projects to enhance the demand for medical coatings
                               TABLE 51 INDIA: MEDICAL COATINGS MARKET SIZE, BY APPLICATION, 2018–2025 (TON)
                               TABLE 52 INDIA: MEDICAL COATINGS MARKET SIZE, BY APPLICATION, 2018–2025 (USD MILLION)
           9.4.5 AUSTRALIA
                    9.4.5.1 Increased life expectancy to indirectly fuel the demand for medical devices
                               TABLE 53 AUSTRALIA: MEDICAL COATINGS MARKET SIZE, BY APPLICATION, 2018–2025 (TON)
                               TABLE 54 AUSTRALIA: MEDICAL COATINGS MARKET SIZE, BY APPLICATION, 2018–2025 (USD MILLION)
           9.4.6 REST OF APAC
                    TABLE 55 REST OF APAC: MEDICAL COATINGS MARKET SIZE, BY APPLICATION, 2018–2025 (TON)
                    TABLE 56 REST OF APAC: MEDICAL COATINGS MARKET SIZE, BY APPLICATION, 2018–2025 (USD MILLION)
    9.5 SOUTH AMERICA
           TABLE 57 SOUTH AMERICA: MEDICAL COATINGS MARKET SIZE, BY COUNTRY, 2018–2025 (KILOTON)
           TABLE 58 SOUTH AMERICA: MEDICAL COATINGS MARKET SIZE, BY COUNTRY, 2018–2025 (USD MILLION)
           TABLE 59 SOUTH AMERICA: MEDICAL COATINGS MARKET SIZE, BY APPLICATION, 2018–2025 (KILOTON)
           TABLE 60 SOUTH AMERICA: MEDICAL COATINGS MARKET SIZE, BY APPLICATION, 2018–2025 (USD MILLION)
           9.5.1 BRAZIL
                    9.5.1.1 Increasing domestic production of medical devices to drive the market
                               TABLE 61 BRAZIL: MEDICAL COATINGS MARKET SIZE, BY APPLICATION, 2018–2025 (KILOTON)
                               TABLE 62 BRAZIL: MEDICAL COATINGS MARKET SIZE, BY APPLICATION, 2018–2025 (USD MILLION)
           9.5.2 ARGENTINA
                    9.5.2.1 Increasing risk of non-communicable diseases to boost the demand
                               TABLE 63 ARGENTINA: MEDICAL COATINGS MARKET SIZE, BY APPLICATION, 2018–2025 (TON)
                               TABLE 64 ARGENTINA: MEDICAL COATINGS MARKET SIZE, BY APPLICATION, 2018–2025 (USD MILLION)
           9.5.3 REST OF SOUTH AMERICA
                    TABLE 65 REST OF SOUTH AMERICA: MEDICAL COATINGS MARKET SIZE, BY APPLICATION, 2018–2025 (TON)
                    TABLE 66 REST OF SOUTH AMERICA: MEDICAL COATINGS MARKET SIZE, BY APPLICATION, 2018–2025 (USD MILLION)
    9.6 MIDDLE EAST AND AFRICA
           TABLE 67 MIDDLE EAST & AFRICA: MEDICAL COATINGS MARKET SIZE, BY COUNTRY, 2018–2025 (KILOTON)
           TABLE 68 MIDDLE EAST & AFRICA: MEDICAL COATINGS MARKET SIZE, BY COUNTRY, 2018–2025 (USD MILLION)
           TABLE 69 MIDDLE EAST & AFRICA: MEDICAL COATINGS MARKET SIZE, BY APPLICATION, 2018–2025 (KILOTON)
           TABLE 70 MIDDLE EAST & AFRICA: MEDICAL COATINGS MARKET SIZE, BY APPLICATION, 2018–2025 (USD MILLION)
           9.6.1 SAUDI ARABIA
                    9.6.1.1 Government initiatives for healthcare industry to drive the market
                               TABLE 71 SAUDI ARABIA: MEDICAL COATINGS MARKET SIZE, BY APPLICATION, 2018–2025 (TON)
                               TABLE 72 SAUDI ARABIA: MEDICAL COATINGS MARKET SIZE, BY APPLICATION, 2018–2025 (USD MILLION)
           9.6.2 SOUTH AFRICA
                    9.6.2.1 Investments by global medical device companies to drive the medical coatings market
                               TABLE 73 SOUTH AFRICA: MEDICAL COATINGS MARKET SIZE, BY APPLICATION, 2018–2025 (TON)
                               TABLE 74 SOUTH AFRICA: MEDICAL COATINGS MARKET SIZE, BY APPLICATION, 2018–2025 (USD MILLION)
           9.6.3 UAE
                    9.6.3.1 Diversification of economy to propel the demand for medical coatings
                               TABLE 75 UAE: MEDICAL COATINGS MARKET SIZE, BY APPLICATION, 2018–2025 (TON)
                               TABLE 76 UAE: MEDICAL COATINGS MARKET SIZE, BY APPLICATION, 2018–2025 (USD MILLION)
           9.6.4 REST OF MIDDLE EAST & AFRICA
                    TABLE 77 REST OF MIDDLE EAST & AFRICA: MEDICAL COATINGS MARKET SIZE, BY APPLICATION, 2018–2025 (TON)
                    TABLE 78 REST OF MIDDLE EAST & AFRICA: MEDICAL COATINGS MARKET SIZE, BY APPLICATION, 2018–2025 (USD MILLION)

10 COMPETITIVE LANDSCAPE (Page No. - 120)
     10.1 OVERVIEW
               FIGURE 29 COMPANIES ADOPTED INVESTMENT & EXPANSION AS THE KEY GROWTH STRATEGY BETWEEN 2016 AND 2020
     10.2 COMPETITIVE LEADERSHIP MAPPING, 2019
             10.2.1 VISIONARY LEADERS
             10.2.2 INNOVATORS
             10.2.3 DYNAMIC DIFFERENTIATORS
             10.2.4 EMERGING COMPANIES
                       FIGURE 30 MEDICAL COATINGS MARKET: COMPETITIVE LEADERSHIP MAPPING, 2019
     10.3 COMPETITIVE BENCHMARKING
               FIGURE 31 PRODUCT PORTFOLIO ANALYSIS OF TOP PLAYERS IN MEDICAL COATINGS MARKET
             10.3.1 BUSINESS STRATEGY EXCELLENCE
                       FIGURE 32 BUSINESS STRATEGY EXCELLENCE OF TOP PLAYERS IN MEDICAL COATINGS MARKET
     10.4 MARKET RANKING OF KEY PLAYERS
     10.5 MARKET SHARE ANALYSIS
     10.6 COMPETITIVE SITUATION & TRENDS
             10.6.1 PARTNERSHIP
                       TABLE 79 PARTNERSHIP (2016–2020)
             10.6.2 NEW PRODUCT DEVELOPMENT
                       TABLE 80 NEW PRODUCT DEVELOPMENT (2016–2020)
             10.6.3 MERGER & ACQUISITION
                       TABLE 81 MERGER & AQUISITION (2016–2020)
             10.6.4 AGREEMENT & COLLABORATION
                       TABLE 82 AGREEMENT & COLLABORATION (2016–2020)
             10.6.5 INVESTMENT & EXPANSION
                       TABLE 83 INVESTMENT & EXPANSION (2016–2020)

11 COMPANY PROFILES (Page No. - 132)
(Business Overview, Products Offered, Recent Developments, SWOT Analysis, MnM View)*
     11.1 HYDROMER
               FIGURE 33 HYDROMER: COMPANY SNAPSHOT
               FIGURE 34 HYDROMER: SWOT ANALYSIS
     11.2 DSM
               FIGURE 35 DSM: COMPANY SNAPSHOT
               TABLE 84 WALLET SHARE OF END-USE MARKET FOR DSM
               FIGURE 36 DSM: SWOT ANALYSIS
     11.3 SURMODICS
               FIGURE 37 SURMODICS: COMPANY SNAPSHOT
               FIGURE 38 SURMODICS: SWOT ANALYSIS
     11.4 BIOCOAT
               FIGURE 39 BIOCOAT INC.: SWOT ANALYSIS
     11.5 AST PRODUCTS INC.
     11.6 COVALON TECHNOLOGIES LTD.
     11.7 FREUDENBERG MEDICAL
     11.8 MERIT MEDICAL OEM
     11.9 HARLAND MEDICAL SYSTEMS INC.
     11.10 APPLIED MEDICAL COATINGS
     11.11 OTHERS
               11.11.1 APPLIED MEMBRANE TECHNOLOGIES
               11.11.2 A&A COATINGS
               11.11.3 CALICO COATINGS
               11.11.4 COATINGS2GO
               11.11.5 CURTISS WRIGHT CORPORATION
               11.11.6 ENCAPSON
               11.11.7 ENDURA COATINGS
               11.11.8 HTI TECHNOLOGIES
               11.11.9 MATERION CORPORATION
               11.11.10 MEDICOAT
               11.11.11 MILLER-STEPHENSON
               11.11.12 PRECISION COATING TECHNOLOGY & MANUFACTURING
               11.11.13 SPECIALTY COATINGS SYSTEMS
               11.11.14 SURFACE TECHNOLOGY
               11.11.15 WHITFORD

*Details on Business Overview, Products Offered, Recent Developments, SWOT Analysis, MnM View might not be captured in case of unlisted companies.

12 ADJACENT/RELATED MARKETS (Page No. - 158)
     12.1 INTRODUCTION
     12.2 LIMITATION
     12.3 PAINTS & COATINGS ECOSYSTEM AND INTERCONNECTED MARKET
     12.4 CATHETERS
             12.4.1 MARKET DEFINITION
             12.4.2 MARKET OVERVIEW
             12.4.3 CATHETERS MARKET, BY RESIN TYPE
                       TABLE 85 CATHETERS MARKET, BY TYPE, 2018–2025 (USD MILLION)
                       12.4.3.1 Cardiovascular Catheters
                       TABLE 86 CARDIOVASCULAR CATHETERS MARKET, BY TYPE, 2018–2025 (USD MILLION)
                                   12.4.3.1.1 Electrophysiology Catheters
                                                    12.4.3.1.1.1 Electrophysiology catheters dominate the cardiovascular catheters market
                                   12.4.3.1.2 Angiography Catheters
                                                    12.4.3.1.2.1 Benefits of angiography have supported the demand for related catheters
                                   12.4.3.1.3 Balloon Catheters
                                                    12.4.3.1.3.1 Demand for balloon catheters is expected to inflate in the APAC
                                   12.4.3.1.4 IVUS/OCT Catheters
                                                    12.4.3.1.4.1 Penetration of market products is higher in Japan as compared to the US and Europe
                                   12.4.3.1.5 Guiding Catheters
                                                    12.4.3.1.5.1 Rising number of interventional and angiography procedures will drive market growth
                       12.4.3.2 Intravenous Catheters
                                   TABLE 87 INTRAVENOUS CATHETERS MARKET, BY TYPE, 2018–2025 (USD MILLION)
                                   12.4.3.2.1 Central Venous Catheters
                                                    TABLE 88 CENTRAL VENOUS CATHETERS MARKET, BY TYPE, 2018–2025 (USD MILLION)
                                   12.4.3.2.2 Peripherally Inserted Central Catheters
                                                    12.4.3.2.2.1 PICCs dominate the central venous catheters market
                                   12.4.3.2.3 Non-tunneled central catheters
                                                    12.4.3.2.3.1 Non-tunneled catheters are mainly used for short-term access
                                   12.4.3.2.4 Skin-tunneled Central Catheters
                                                    12.4.3.2.4.1 Skin-tunneled catheters are used for long-term access and feature a low infection risk
                                   12.4.3.2.5 Implantable Ports
                                                    12.4.3.2.5.1 High convenience and minimized risk of infection has supported the adoption of implantable ports
                                   12.4.3.2.6 Peripheral Catheters
                                                    12.4.3.2.6.1 Large usage of these devices is the key driver of market growth
                                   12.4.3.2.7 Midline Peripheral Catheters
                                                    12.4.3.2.7.1 The use of midline peripheral catheters has declined in recent years
                       12.4.3.3 Urological Catheters
                                   TABLE 89 UROLOGICAL CATHETERS MARKET, BY TYPE, 2018–2025 (USD MILLION)
                                   12.4.3.3.1 Urinary Catheters
                                                    TABLE 90 URINARY CATHETERS MARKET, BY TYPE, 2018–2025 (USD MILLION)
                                                    TABLE 91 URINARY CATHETERS MARKET, BY TYPE, 2018–2025 (MILLION UNITS)
                                   12.4.3.3.2 Indwelling/Foley Catheters
                                                    12.4.3.3.2.1 Indwelling/Foley catheters dominate the urinary catheters market
                                   12.4.3.3.3 Intermittent Catheters
                                                    12.4.3.3.3.1 Intermittent catheters will grow at the highest CAGR during the forecast period
                                   12.4.3.3.4 External Catheters
                                                    12.4.3.3.4.1 Minimized risk of damage to the urethra and infections drive the market for external catheters
                       12.4.3.4 Dialysis Catheters
                                   TABLE 92 DIALYSIS CATHETERS MARKET, BY TYPE, 2018–2025 (USD MILLION)
                                   12.4.3.4.1 Peritoneal Dialysis Catheters
                                                    12.4.3.4.1.1 Development of new approaches for PD catheter placement is driving their adoption
                                   12.4.3.4.2 Hemodialysis Catheters
                                                    12.4.3.4.2.1 Hemodialysis catheters can be used for the long-term if fistulas and grafts are unsuccessful
                       12.4.3.5 Specialty Catheters
                                   TABLE 93 SPECIALTY CATHETERS MARKET, BY TYPE, 2018–2025 (USD MILLION)
                                   12.4.3.5.1 Pressure & Hemodynamic Monitoring Catheters
                                                    12.4.3.5.1.1 Benefits such as continuous monitoring capabilities and a wide range of applications are driving segmental growth
                                   12.4.3.5.2 Temperature Monitoring Catheters
                                                    12.4.3.5.2.1 Accuracy and need for vital sign monitoring have driven demand for temperature monitoring catheters
                                   12.4.3.5.3 Intrauterine Insemination Catheters
                                                    12.4.3.5.3.1 IUI catheters are commonly used in infertility cases and for sonohysterography
                                   12.4.3.5.4 Other Specialty Catheters
                       12.4.3.6 Neurovascular Catheters
                                   12.4.3.6.1 Rising incidence of neurological disorders is driving the market for neurovascular catheters
             12.4.4 CATHETERS MARKET, BY END USER
                       TABLE 94 CATHETERS MARKET, BY END USER, 2018–2025 (USD MILLION)
                       12.4.4.1 Hospitals
                                   12.4.4.1.1 High patient inflow and procedural volumes make hospitals the largest end users of catheters
                       12.4.4.2 Long-term care facilities
                                   12.4.4.2.1 Growing demand for long-term care supports the growth of this end-user segment
                       12.4.4.3 Diagnostic Imaging centers
                                   12.4.4.3.1 Efficiency, convenience, and affordability of imaging centers drive the growth of this end-user segment
                       12.4.4.4 Other end users
             12.4.5 CATHETERS MARKET, BY REGION
                       TABLE 95 CATHETERS MARKET, BY REGION, 2018–2025 (USD MILLION)
                       12.4.5.1 North America
                       12.4.5.2 Europe
                       12.4.5.3 APAC
                       12.4.5.4 ROW
     12.5 ACTIVE IMPLANTABLE MEDICAL DEVICE MARKET
             12.5.1 MARKET DEFINITION
             12.5.2 MARKET OVERVIEW
             12.5.3 ACTIVE IMPLANTABLE MEDICAL DEVICE MARKET, BY PRODUCT TYPE
                       TABLE 96 GLOBAL ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY PRODUCT, 2015–2022 (USD MILLION)
                       12.5.3.1 Implantable cardioverter defibrillators
                                   TABLE 97 GLOBAL IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY PRODUCT TYPE, 2015–2022 (USD MILLION)
                                   12.5.3.1.1 Transvenous Implantable Cardioverter Defibrillators
                                                    TABLE 98 GLOBAL TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY PRODUCT TYPE, 2015-2022 (USD MILLION)
                                                    12.5.3.1.1.1 Biventricular Implantable Cardioverter Defibrillators (ICDs)/Cardiac Resynchronization Therapy Defibrillators (CRT-Ds)
                                                    12.5.3.1.1.2 Dual-Chamber Implantable Cardioverter Defibrillators
                                                    12.5.3.1.1.3 Single-Chamber Implantable Cardioverter Defibrillators
                                   12.5.3.1.2 Subcutaneous Implantable Cardioverter Defibrillators
                       12.5.3.2 Implantable cardiac pacemakers
                       12.5.3.3 Ventricular assist devices
                       12.5.3.4 Implantable heart monitors/Insertable loop recorders
                       12.5.3.5 Neurostimulators
                                   TABLE 99 NEUROSTIMULATORS MARKET SIZE, BY PRODUCT TYPE, 2015-2022 (USD MILLION)
                                   12.5.3.5.1 Spinal cord stimulators
                                   12.5.3.5.2 Deep brain stimulators
                                   12.5.3.5.3 Sacral nerve stimulators
                                   12.5.3.5.4 Vagus nerve stimulators
                                   12.5.3.5.5 Gastric electrical stimulators
                                   12.5.3.5.6 Implantable hearing devices
                                                    TABLE 100 IMPLANTABLE HEARING DEVICES MARKET SIZE, BY PRODUCT TYPE, 2015-2022 (USD MILLION)
                                                    12.5.3.5.6.1 Active hearing Implants
                                                    12.5.3.5.6.2 Passive hearing implants
             12.5.4 ACTIVE IMPLANTABLE MEDICAL DEVICE MARKET, BY REGION
                       TABLE 101 GLOBAL ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SIZE, BY REGION, 2015–2022 (USD MILLION)
                       12.5.4.1 NORTH AMERICA
                       12.5.4.2 EUROPE
                       12.5.4.3 ASIA-PACIFIC
                       12.5.4.4 LATIN AMERICA
                       12.5.4.5 MIDDLE EAST AND AFRICA

13 APPENDIX (Page No. - 186)
     13.1 DISCUSSION GUIDE
     13.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
     13.3 AVAILABLE CUSTOMIZATIONS
     13.4 RELATED REPORTS
     13.5 AUTHOR DETAILS

The study involved four major activities in estimating the current size of the medical coatings market. Exhaustive secondary research was done to collect information on the market, the peer market, and the parent market. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. Both top-down and bottom-up approaches were employed to estimate the complete market size. After that, market breakdown and data triangulation were used to estimate the market size of segments and sub-segments. 

Secondary Research 

In the secondary research process, various secondary sources, such as Hoovers, Bloomberg Businessweek, Factiva, World Bank, World Health Organization’s database, United Nations Database, and Industry Journals, were referred to for identifying and collecting information for this study. These secondary sources included annual reports, press releases & investor presentations of companies, white papers, certified publications, articles by recognized authors, and databases. 

Primary Research 

The medical coatings market comprises several stakeholders, such as raw material suppliers, processors, end-product manufacturers, and regulatory organizations in the supply chain. The supply side of this market includes lab technicians, technologists, and sales managers from the medical coatings industry. On the other hand, the demand side is characterized by advancements in technology and diverse application segments. Various primary sources from both the supply and demand sides of the market were interviewed to obtain qualitative and quantitative information.

 Following is the breakdown of primary respondents

Medical Coatings Market Size

To know about the assumptions considered for the study, download the pdf brochure

Market Size Estimation

Both the top-down and bottom-up approaches were used to estimate and validate the total size of the medical coatings market. These methods were also used extensively to determine the size of various sub-segments in the market. The research methodology used to estimate the market size included the following: 

  • The key players in the industry and markets were identified through extensive secondary research.
  •  Market sizes, in terms of value and volume, were determined through primary and secondary research processes.
  • All percentage shares, splits, and breakdowns were determined using secondary sources and verified through primary sources. 

Data Triangulation 

After arriving at the overall market size using the medical coatings market size estimation processes explained above, the market was split into several segments and sub-segments. To complete the overall market engineering process and arrive at the exact statistics of each market segment and sub-segment, the data triangulation, and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides in various end-use industries. 

Report Objectives:

  • To define, describe, and forecast the medical coatings market size, in terms of value and volume
  • To provide detailed information about the key factors (drivers, restraints, opportunities, and challenges) influencing the market growth
  • To analyze and forecast the market by coating type, substrate type, material type, and application
  • To forecast the size of the market with respect to five regions: Asia Pacific (APAC), Europe, North America, South America, and the Middle East & Africa, along with their key countries
  • To strategically analyze micromarkets1 with respect to individual trends, growth prospects, and their contribution to the overall market
  • To analyze the opportunities in the market for stakeholders and provide a competitive landscape for market leaders
  • To strategically analyze the markets with respect to ongoing trends in various applications during the COVID-19 pandemic
  • To analyze the competitive developments, such as agreement & collaboration, new product development, investment & expansion, partnership, and merger & acquisition, in the market
  • To strategically profile the key players and comprehensively analyze their market shares and core competencies2

Available Customizations:

With the given market data, MarketsandMarkets offers customizations according to the company’s specific needs. The following customization options are available for the report: 

Product Analysis 

Product matrix, which gives a detailed comparison of the product portfolio of each company 

Regional Analysis

  • Further breakdown of the Rest of APAC, Rest of Europe, Rest of South America, and Rest of Middle East & Africa for medical coatings market 

Company Information

  • Detailed analysis and profiling of additional market players (up to five)
COVID-19

Get in-depth analysis of the COVID-19 impact on the Medical Coatings Market

Benchmarking the rapid strategy shifts of the Top 100 companies in the Medical Coatings Market

Request For Special Pricing
Report Code
CH 3023
Published ON
Aug, 2020
Choose License Type
BUY NOW
  • SHARE
X
Request Customization
Speak to Analyst
Speak to Analyst
OR FACE-TO-FACE MEETING
PERSONALIZE THIS RESEARCH
  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
REQUEST A FREE CUSTOMIZATION
LET US HELP YOU!
  • What are the Known and Unknown Adjacencies Impacting the Medical Coatings Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
CUSTOMIZED WORKSHOP REQUEST
ADJACENT MARKETS
REQUEST BUNDLE REPORTS
+1-888-600-6441
  • Call Us
  • +1-888-600-6441 (Corporate office hours)
  • +1-888-600-6441 (US/Can toll free)
  • +44-800-368-9399 (UK office hours)
CONNECT WITH US
ABOUT TRUST ONLINE
©2021 MarketsandMarkets Research Private Ltd. All rights reserved
...

Digital Virtual Assistant - MarketsandMarkets

Home